BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25670512)

  • 21. Integrating VA's NDF-RT drug terminology with PharmGKB: preliminary results.
    Pathak J; Weiss LC; Durski MJ; Zhu Q; Freimuth RR; Chute CG
    Pac Symp Biocomput; 2012; ():400-9. PubMed ID: 22174295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenetics research network and knowledge base: 1st annual scientific meeting.
    Davis A; Long R
    Pharmacogenomics; 2001 Aug; 2(3):285-9. PubMed ID: 11939133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A resource to acquire and summarize pharmacogenetics knowledge in the literature.
    Rubin DL; Carrillo M; Woon M; Conroy J; Klein TE; Altman RB
    Stud Health Technol Inform; 2004; 107(Pt 2):793-7. PubMed ID: 15360921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basic Concepts in Genetics and Pharmacogenomics for Pharmacists.
    Orrico KB
    Drug Target Insights; 2019; 13():1177392819886875. PubMed ID: 31832012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A statistical approach to scanning the biomedical literature for pharmacogenetics knowledge.
    Rubin DL; Thorn CF; Klein TE; Altman RB
    J Am Med Inform Assoc; 2005; 12(2):121-9. PubMed ID: 15561790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
    Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
    Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Installing a Local Copy of the Reactome Web Site and Knowledgebase.
    McKay SJ; Weiser J
    Curr Protoc Bioinformatics; 2015 Jun; 50():9.10.1-9.10.10. PubMed ID: 26087747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrating large-scale genotype and phenotype data.
    Hernandez-Boussard T; Woon M; Klein TE; Altman RB
    OMICS; 2006; 10(4):545-54. PubMed ID: 17233563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of computational predictions of the functional effect of idiosyncratic pharmacogenetic variants.
    McConnell H; Andrews TD; Field MA
    PeerJ; 2021; 9():e11774. PubMed ID: 34316407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical genomics data standards for pharmacogenetics and pharmacogenomics.
    Shabo A
    Pharmacogenomics; 2006 Mar; 7(2):247-53. PubMed ID: 16515405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of plasmid-derived external quality control samples in pharmacogenetic testing.
    van der Straaten T; Swen J; Baak-Pablo R; Guchelaar HJ
    Pharmacogenomics; 2008 Sep; 9(9):1261-6. PubMed ID: 18781854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group.
    Bromley CM; Close S; Cohen N; Favis R; Fijal B; Gheyas F; Liu W; Lopez-Correa C; Prokop A; Singer JB; Snapir A; Tchelet A; Wang D; Goldstaub D;
    Pharmacogenomics J; 2009 Feb; 9(1):14-22. PubMed ID: 18794908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. International Conference on Harmonisation; Guidance on E15 Pharmacogenomics Definitions and Sample Coding; Availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Apr; 73(68):19074-6. PubMed ID: 18677821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leveraging a pharmacogenomics knowledgebase to formulate a drug response phenotype terminology for genomic medicine.
    Zhao Y; Brush M; Wang C; Wagner AH; Liu H; Freimuth RR
    Bioinformatics; 2022 Nov; 38(23):5279-5287. PubMed ID: 36222570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MACdb: A Curated Knowledgebase for Metabolic Associations across Human Cancers.
    Sun Y; Zheng X; Wang G; Wang Y; Chen X; Sun J; Xiong Z; Zhang S; Wang T; Fan Z; Bu C; Bao Y; Zhao W
    Mol Cancer Res; 2023 Jul; 21(7):691-697. PubMed ID: 37027007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automating data acquisition into ontologies from pharmacogenetics relational data sources using declarative object definitions and XML.
    Rubin DL; Hewett M; Oliver DE; Klein TE; Altman RB
    Pac Symp Biocomput; 2002; ():88-99. PubMed ID: 11928521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BrainBase: a curated knowledgebase for brain diseases.
    Liu L; Zhang Y; Niu G; Li Q; Li Z; Zhu T; Feng C; Liu X; Zhang Y; Xu T; Chen R; Teng X; Zhang R; Zou D; Ma L; Zhang Z
    Nucleic Acids Res; 2022 Jan; 50(D1):D1131-D1138. PubMed ID: 34718720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward an integrated knowledge environment to support modern oncology.
    Blake PM; Decker DA; Glennon TM; Liang YM; Losko S; Navin N; Suh KS
    Cancer J; 2011; 17(4):257-63. PubMed ID: 21799334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Designing and implementing special-purpose databases: lessons from the pharmacogenetic network.
    Nadkarni P; Sun K; Wiepert M
    Pharmacogenomics; 2002 Sep; 3(5):687-96. PubMed ID: 12223053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linking PharmGKB to phenotype studies and animal models of disease for drug repurposing.
    Hoehndorf R; Oellrich A; Rebholz-Schuhmann D; Schofield PN; Gkoutos GV
    Pac Symp Biocomput; 2012; ():388-99. PubMed ID: 22174294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.